Filiz Sarah Gärtner

Meet our CODE_n CONTEST Finalists 2016: NovioSense from the Netherlands

noviosense_logoNovioSense, CODE_n CONTEST Finalist in the HealthTech cluster, is a medical sensor company that develops cellphone-powered sensor devices for glucose monitoring in diabetics. Their first product is a non-invasive, wireless, cellphone-powered sensor that measures glucose levels in tears. CEO Dr. Christopher Wilson, has run us through his vision for the young Dutch company – which is quite amazing. Read for yourself!

What is noviosense all about? How did you come up with the idea?

Christopher: NovioSense is all about changing the status quo in diabetes monitoring. We are going to bring a non-invasive glucose monitor with the accuracy of minimally invasive devices at a price point that is accessible to all diabetics. The idea first came from two of my shareholders – they wanted to make a device that measures glucose in tears for type 1 diabetics. Type 1 diabetics are still part of the plan but over the past five years since founding the company and starting to raise the capital, we realised that this solution could be a whole lot more than a niche device. Providing the patient with the ability to take the equivalent of infinite finger pricks without pain and at a price point that is accessible to all opens the door to a market ten times larger than the original concept. Aside from the market size, it is something that all stakeholders want. We talked to doctors who told us that if we can be as accurate and reliable as the current devices but encourage patients to test more and take a more proactive role in the control of their disease. More…